TY  - BOOK
AU  - Bernheim,Molly
ED  - Symposium on Monoamine Oxidase and its Inhibition
ED  - ProQuest (Firm)
TI  - Monoamine oxidase and its inhibition: in honour of Mary L. C. Bernheim
T2  - Ciba Foundation symposium ; 39 (new ser.)
AV  - QP603.M6 S95 1975
U1  - 612/.0151/8 22
PY  - 1976///
CY  - Amsterdam, New York
PB  - Elsevier/Excerpta Medica/North-Holland
KW  - Monoamine oxidase
KW  - Congresses
KW  - Inhibitors
KW  - Electronic books
N1  - Includes bibliographical references and indexes; Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis; Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries
UR  - https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=703863
ER  -